Mesoporous Silica Nanoparticles in Biomedicine: Advances and Prospects
Advanced Materials · 2026-09 · 38 (51)
DOI: 10.1002/adma.202512433 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Materials, online erschienen am 25.08.2025. Verfasst von Miguel Manzano und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry in Pharmaceutical Sciences, School of Pharmacy, Institute Hospital 12 de Octubre (Imas12), Universidad Complutense de Madrid …. Hauptthemen laut MEDLINE: Silicon Dioxide, Nanoparticles. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 205 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Comunidad de Madrid, Transformation and Resilience plan, Next Generation EU.
Abstract (Originalsprache)
Mesoporous Silica Nanoparticles (MSNs) represent a versatile platform in biomedicine thanks to their unique structural properties and functional versatility. These nanoparticles are at the forefront, offering exceptional biocompatibility, tunable pore sizes, and surface functionalization to enhance drug loading and controlled release. On top of that, stimuli‐responsive MSNs can be designed to respond to specific triggers such as pH, temperature, or light. These smart MSNs further optimize drug delivery by ensuring targeted release and minimizing side effects. Beyond drug delivery applications, mesoporous materials are increasingly utilized in tissue regeneration, providing scaffolds that promote cell growth and integration. In bone‐related pathologies, these materials exhibit significant potential, enhancing mineralization and facilitating the repair of osseous defects. Future perspectives focus on advancing the multifunctionality of MSNs, integrating imaging, therapeutic, and diagnostic capabilities into single platforms. The remarkable adaptability of MSNs ensures their continued evolution, paving the way for innovative solutions to complex biomedical challenges.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry in Pharmaceutical Sciences, School of Pharmacy, Institute Hospital 12 de Octubre (Imas12), Universidad Complutense de Madrid (UCM), Madrid, 28040, Spain.
- Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, 28029, Spain.
ORCID-Profile: María Vallet-Regí
Förderung
- Comunidad de Madrid
- Transformation and Resilience plan
- Next Generation EU
- European Union
- HORIZON EUROPE European Research Council
- Spanish National Plan for Scientific and Technical Research and Innovation
- European Commission
Zitieren
APA
Manzano, M., & Vallet-Regí, M. (2026). Mesoporous Silica Nanoparticles in Biomedicine: Advances and Prospects. Advanced Materials, 38(51). https://doi.org/10.1002/adma.202512433
Vancouver
Manzano M, Vallet-Regí M. Mesoporous Silica Nanoparticles in Biomedicine: Advances and Prospects. Advanced Materials. 2026;38(51). doi:10.1002/adma.202512433
BibTeX
@article{Manzano2026,
author = {Manzano, Miguel and Vallet-Regí, María},
title = {Mesoporous Silica Nanoparticles in Biomedicine: Advances and Prospects},
journal = {Advanced Materials},
year = {2026},
volume = {38},
number = {51},
doi = {10.1002/adma.202512433}
}
EUVIMED